Skip to Content

Diagnostic Pathology Course

January 10, 2015

The University of Texas MD Anderson Cancer Center 
South Campus Research Building 
7455 Fannin Street
Houston, TX 77030

General Information

Goal

This conference will focus on major areas of interest to general surgical pathologists, including recently implemented diagnostic and prognostic molecular tests that will improve the accuracy of clinical histopathologic diagnoses; updated information on current tumor grading systems; and discussion of areas of diagnostic difficulty along with the information needed to avoid diagnostic errors when these issues are encountered.

Educational Objectives

At the conclusion of this educational activity, participants should be able to

  • Apply updated diagnostic criteria and new molecular tests for proper classification and treatment of neoplastic lesions (knowledge, competence, performance, patient outcomes)
  • Incorporate emerging and newly established biomarkers in immunohistochemical classification and surgical pathology for accurate prognosis and treatment plans (knowledge, competence, performance, patient outcomes)
  • Practice appropriate use of molecular testing and tumor diagnosis (knowledge, competence, performance)
  • Incorporate emerging and newly established HPB tests in tumor classification and daily practice to improve patient outcomes (knowledge, competence, performance, patient outcomes)

Target Audience

The course will be of value to practicing pathologists and pathology trainees.

Evaluation

A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status.  Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

Accreditation/Credit Designation

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™.  Physicians should claim only credit commensurate with the extent of their participation in the activity.

CME Certificates and Attendance Verification Certificates

Certificates awarding AMA PRA Category 1 Credits™ or certificates documenting attendance will be distributed to participants when an individual departs the conference.  To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.

Upon request, a record of attendance (certificate) will be provided on-site to other healthcare professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented.  MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products.  Specific disclosure will be made to the participants prior to the educational activity.  

Agendas are subject to change because we are always striving to improve the quality of your educational experience.  MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth.


© 2014 The University of Texas MD Anderson Cancer Center